Skip to main content

Table 2 Patient demography and baseline characteristics

From: Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

  Remifentanil/propofol Midazolam/fentanyl
Number of patients analysed 39 33
Mean age (years) 65 ± 8.1 66.5 ± 7.0
Male/female 30/9 23/10
Mean height (cm)/weight (kg) 169.9 ± 8.8/80.1 ± 12.7 170.5 ± 7.1/83.9 ± 12.1
ASA physical status (I/II/III) 0/0/39 0/0/33
Type of surgerya   
   Bypass surgery 33 31
   Valve surgery 11 8
Mean ejection fraction (%) at screening 49.5 ± 12.7 50.3 ± 15.8
Mean SAPS II on admission 37.6 ± 14.2 28.2 ± 11.7
  1. Values are number of patients or mean ± standard deviation. aMultiple counts are possible per subject. SAPS, simplified acute physiology score.